Patents by Inventor Addanki P. Kumar

Addanki P. Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agents and methods for the prevention of initial onset of cancers, the treatment of cancers, and the recurrence of existing cancers
    Publication number: 20040116397
    Abstract: The use of 2-methoxyestradiol, analogues of 2-methoxyestradiol, their method of synthesis and therapeutic use, and the use of combinations of the 2-methoxyestradiol and its analogues, with and without synergistic compounds (namely eugenol), all in the prevention of initial onset cancers, treatment of existing cancers, and the recurrence of previously existing cancers.
    Type: Application
    Filed: May 21, 2003
    Publication date: June 17, 2004
    Inventors: Tom J Slaga, Addanki P Kumar, William Alworth
  • Method and composition of novel compounds for the therapy and targeting of the primary modalitites of cancer cell proliferation and homeostasis
    Publication number: 20040053906
    Abstract: The invention is of both a composition and method for inhibiting the proliferation of cancerous cells. The composition is, and the method is based on the use of a composition consisting (among active ingredients) substantially of 2-methoxyestradiol and/or one of a number of anaologues thereof. The present inventors have demonstrated beyond serious doubt that these compounds have a pronounced effect in inhibiting the proliferation of cancerous cells and, therefore, provide a desperately needed stepping stone for advancing toward meaningful treatment of cancer.
    Type: Application
    Filed: June 25, 2003
    Publication date: March 18, 2004
    Applicant: Oncology Sciences Corporation
    Inventors: Thomas J. Slaga, Addanki P. Kumar, William Allworth
  • Agents and methods for the prevention of initial onset of cancers, the treatment of cancers, and the recurrence of existing cancers
    Publication number: 20030073674
    Abstract: The use of 2-methoxyestradiol, analogues of 2-methoxyestradiol, their method of synthesis and therapeutic use, and the use of combinations of the 2 methoxyestradiol and its analogues, with and without synergistic compounds (namely eugenol), all in the prevention of initial onset cancers, treatment of existing cancers, and the recurrence of previously existing cancers.
    Type: Application
    Filed: September 17, 2002
    Publication date: April 17, 2003
    Applicant: Oncology Sciences Corporation
    Inventors: Thomas J. Slaga, Addanki P. Kumar, William Alworth
  • Use of 2-ME in promotion of apoptosis in the prevention of initial onset and recurrence of existing cancers
    Publication number: 20030036539
    Abstract: The use of 2-methoxyestradiol in the prevention of initial onset cancers and the recurrence of previously existing cancers, through use of such compound in a manner to promoteo pro-apoptotic activities in target cells and tissues.
    Type: Application
    Filed: August 1, 2002
    Publication date: February 20, 2003
    Applicant: Oncology Sciences Corporation
    Inventors: Thomas J. Slaga, Addanki P. Kumar
  • Use of eugenol in combination with other chemopreventative agents as prophylaxis for cancers
    Patent number: 6518261
    Abstract: The use of eugenol, alone and in combination with 2-methoxyestradiol (2-ME) in the context of prostate cancer prophylaxes and treatment.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: February 11, 2003
    Assignee: Oncology Sciences Corporation
    Inventors: Thomas J. Slaga, Addanki P. Kumar, William Alworth
  • Method and composition for inhibiting the incidence and proliferation of nervous system and brain cancer cells
    Publication number: 20030027803
    Abstract: The invention is of both a composition and method for inhibiting the proliferation of cancerous cells, and brain and nervous system cells in particular. The composition is, and the method is based on the use of a composition consisting (among active ingredients) substantially of 2-methoxyestradiol and/or one of a number of analogues thereof. The present inventors have demonstrated beyond serious doubt that these compounds have a pronounced effect in inhibiting the proliferation of cancerous brain and nervous system cells and, therefore, provide a desperately needed stepping stone for advancing toward meaningful treatment of brain and nervous system cancer.
    Type: Application
    Filed: February 6, 2001
    Publication date: February 6, 2003
    Applicant: Oncology Sciences Corporation
    Inventors: Thomas J. Slaga, Addanki P. Kumar, William Alworth
  • Use of eugenol, alone, and in combination with other chemopreventative agents as prophylaxis for cancers
    Publication number: 20020103174
    Abstract: The use of eugenol, alone and in combination with 2-methoxyestradiol (2-ME) in the context of prostate cancer prophylaxes and treatment, and in the treatment and prevention of non-cancerous enlargement of prostate glands.
    Type: Application
    Filed: December 4, 2001
    Publication date: August 1, 2002
    Inventors: Thomas J. Slaga, Addanki P. Kumar, William Alworth
  • Method and composition of novel compounds for the therapy and targeting of the primary modalities of cancer cell proliferation and homeostasis
    Publication number: 20020068724
    Abstract: The invention is of both a composition and method for inhibiting the proliferation of cancerous cells. The composition is, and the method is based on the use of a composition consisting (among active ingredients) substantially of 2-methoxyestradiol and/or one of a number of anaologues thereof. The present inventors have demonstrated beyond serious doubt that these compounds have a pronounced effect in inhibiting the proliferation of cancerous cells and, therefore, provide a desperately needed stepping stone for advancing toward meaningful treatment of cancer.
    Type: Application
    Filed: February 5, 2001
    Publication date: June 6, 2002
    Applicant: Oncology Sciences Corporation
    Inventors: Thomas J. Slaga, Addanki P. Kumar, William Alworth
  • Agents and methods for the prevention of initial onset and recurrence of existing cancers
    Publication number: 20020035098
    Abstract: The use of 2-methoxyestradiol, analogues of 2-methoxyestradiol, their method of synthesis and therapeutic use, and the use of combinations of the 2 methoxyestradiol and its analogues with synergistic compounds (namely eugenol), all in the prevention of initial onset cancers and the recurrence of previously existing cancers.
    Type: Application
    Filed: March 14, 2001
    Publication date: March 21, 2002
    Applicant: Oncology Sciences Corporation
    Inventors: Thomas J. Slaga, Addanki P. Kumar, William Alworth
  • Use of eugenol, alone, and in combination with other chemopreventative agents as prophylaxis for cancers
    Publication number: 20020006918
    Abstract: The use of eugenol, alone and in combination with 2-methoxyestradiol (2-ME) in the context of prostate cancer prophylaxes and treatment.
    Type: Application
    Filed: February 9, 2001
    Publication date: January 17, 2002
    Applicant: Biochemix, Inc.
    Inventors: Thomas J. Slaga, Addanki P. Kumar, William Alworth